Increased risk seen for adverse cardiovascular events, including myocardial infarction, stroke, heart failure, mortality ...

The Food and Drug Administration (FDA) has approved Arbli™, an oral suspension formulation of losartan potassium.  Arbli, an angiotensin II receptor blocker, is indicated for the treatment of ...

Findings seen in pilot study that combines measurements from a depth camera, a forceplate, and an interface board ...

Annual increase of 0.24 percentage points seen in children aged 5 to 17 years and of 0.33 percentage points for young adults age 18 to 25 years ...

Study findings support the monitoring and management of iron status in patients with early stages of chronic kidney disease (CKD).

(HealthDay News) — The global burden of diabetic nephropathy increased from 1990 to 2021, and is projected to continue increasing to 2050, according to a study published online in Frontiers in ...

Venxxiva ™ (tiopronin delayed-release tablet) has been made available for the treatment of cystinuria.

Investigators assessed frailty prevalence in a nationally representative US cohort and inpatient outcomes among kidney transplant recipients.

US cancer patients have reported positive and negative experiences when sharing patient-identified information with their health care providers.

Patients who continued Ozempic through total joint arthroplasty had the highest risk for complications. (HealthDay News) — Stopping glucagon-like peptide-1 receptor agonist (GLP-1 RA) treatment ...

For most patients, definitive treatment with combined modality therapy is recommended. (HealthDay News) — In a clinical practice guideline issued by the American Society for Radiation Oncology ...

Radiation-related bowel toxicity among real-world patients was lower with use of the rectal spacer. Use of a hydrogel rectal spacer reduces the incidence of bowel disorders and related procedures ...